Leerink analyst Michael Cherny downgraded Patterson Companies (PDCO) to Market Perform from Outperform with a price target of $31.35, up from $29, based on the takeout price agreed upon by Patient Square Capital following the company’s go-private transaction. The firm views the multiple paid for the transaction as “reasonable” and thus sees any meaningful “topticking” bid as unlikely, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- Patterson Companies to be acquired by Patient Square for $31.35 per share
- Patterson Companies price target lowered to $24 from $26 at Piper Sandler
- Patterson Companies price target lowered to $25 from $28 at Baird
- Patterson Companies Reports Mixed Q2 Fiscal 2025 Results
- Patterson Companies price target lowered to $24 from $25 at Stifel